528 results on '"Seth, Milan"'
Search Results
52. COMPARATIVE ANALYSIS OF PERCUTANEOUS REVASCULARIZATION PRACTICE IN THE UNITED STATES AND THE UNITED KINGDOM: INSIGHTS FROM THE BMC2 AND BCIS DATABASES
53. CONSCIOUSNESS EQUALS LIFE: SURVIVAL IN CARDIAC ARREST PATIENTS UNDERGOING PCI IS MARKEDLY ASSOCIATED WITH NEUROLOGICAL STATUS
54. BLINDED CROSS-INSTITUIONAL PEER REVIEW ACROSS MICHIGAN: AN INNOVATIVE INITIATIVE FOR IMPROVING PERCUTANEOUS CORONARY INTERVENTION (PCI) APPROPRIATENESS AND QUALITY
55. SAFETY OF SAME-DAY DISCHARGE AFTER ELECTIVE PCI - WHY PUT OFF TO TOMORROW WHAT CAN BE DONE TODAY? INSIGHTS FROM THE BMC2 REGISTRY
56. The optimal definition of contrast-induced acute kidney injury for prediction of inpatient mortality in patients undergoing percutaneous coronary interventions
57. Using simulation for teaching femoral arterial access: A multicentric collaboration
58. Radial PCI and the Obesity Paradox: Insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
59. TCT-56 Effectiveness of Image-Guided Percutaneous Coronary Intervention in Contemporary Practice: Insights From BMC2.
60. TCT-270 Contemporary Use of Mechanical Circulatory Support for the Treatment of Acute Myocardial Infarction Cardiogenic Shock (AMI-CS): Insights From the BMC2 Registry.
61. Abstract 14067: A Novel Tool for Highly Reliable and Accurate Prediction of Multiple Complications in Patients Undergoing Percutaneous Coronary Intervention
62. TCT-220 Impact of Left Ventricular End-Diastolic Pressure on the Outcomes of Patients Undergoing Percutaneous Coronary Intervention
63. Heart Failure Decompensation and All-Cause Mortality in Relation to Percent Biventricular Pacing in Patients With Heart Failure: Is a Goal of 100% Biventricular Pacing Necessary?
64. Marijuana Use and In-Hospital Outcomes After Percutaneous Coronary Intervention in Michigan, United States
65. Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: Implications for primary prevention
66. Differences in sex-related bleeding and outcomes after percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) registry
67. Performance of an Automatic Arrhythmia Classification Algorithm: Comparison to the ALTITUDE Electrophysiologist Panel Adjudications
68. Does change in device detected frequency of non-sustained or diverted episodes serve as a marker for inappropriate shock therapy? Analyses from the INTRINSIC RV and ALTITUDE-REDUCES Trials
69. Trends in Utilization, and Comparative Safety and Effectiveness of Orbital and Rotational Atherectomy
70. The DISCO study—Does Interventionalists' Sex impact Coronary Outcomes?
71. Comparative Safety of Bioabsorbable Polymer Everolimus-Eluting, Durable Polymer Everolimus-Eluting, and Durable Polymer Zotarolimus-Eluting Stents in Contemporary Clinical Practice
72. The Ongoing Importance of Smoking as a Powerful Risk Factor for ST-Segment Elevation Myocardial Infarction in Young Patients
73. Cardiac Rehabilitation Use After Percutaneous Coronary Intervention
74. The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy
75. Real World Evaluation of Dual-Zone ICD and CRT-D Programming Compared to Single-Zone Programming: The ALTITUDE REDUCES Study
76. Implantable Cardioverter Defibrillator Electrogram Adjudication for Device Registries: Methodology and Observations from ALTITUDE
77. TCT CONNECT-122 The Relationship Between Hospital Joint Commission Comprehensive Stroke Center Certification (CSCC) and Stroke Reporting in the National TVT Registry: The Michigan TAVR (MI TAVR) Collaborative Experience
78. Trends and outcomes of non-primary PCI at sites without cardiac surgery on-site: The early Michigan experience
79. Reply
80. Preprocedural statin use in patients undergoing percutaneous coronary intervention
81. The association between patient race, treatment, and outcomes of patients undergoing contemporary percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
82. Trends in Contrast Volume Use and Incidence of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2)
83. Reply
84. TCT-25 Comparative Safety and Effectiveness of Orbital and Rotational Atherectomy in Patients Undergoing Percutaneous Coronary Intervention: Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
85. Relationship Between Troponin on Presentation and In‐Hospital Mortality in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
86. CAN WE FOREGO ROUTINE INTENSIVE CARE UNIT (ICU) ADMISSION IN PATIENTS UNDERGOING PRIMARY PCI FOR STEMI? INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM (BMC2)
87. PREDICTORS OF INTENSIVE CARE UNIT (ICU) UTILIZATION AMONG PATIENTS WITH ST-SEGMENT MYOCARDIAL INFARCTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM (BMC2)
88. TRENDS AND OUTCOMES DURING EARLY ROLLOUT PHASE OF NON-PRIMARY PCI AT CENTERS WITHOUT SURGERY ON-SITE: THE MICHIGAN EXPERIENCE
89. TCT-642 The Comparative Effectiveness and Safety of Cangrelor vs. In- lab Glycoprotein IIb/IIIa Inhibitor (GPI) in Patients Undergoing Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
90. TCT-613 Is Younger Truly Better? Clinical Characteristics and In-Hospital Outcomes of Percutaneous Coronary Intervention Performed in Patients 45 Years Old or Younger
91. TCT-81 The Comparative Effectiveness and Safety of Impella Versus Intra-Aortic Balloon Pump in Patients who Underwent Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
92. TCT-449 Trends in Utilization and Hospital Variation in the use of Mechanical Circulatory Support Devices in Patients Undergoing Percutaneous Coronary Intervention in Michigan: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
93. Contemporary use of and outcomes associated with ultra‐low contrast volume in patients undergoing percutaneous coronary interventions
94. MAGNITUDE AND DETERMINANTS OF VARIATION IN PERCUTANEOUS CORONARY INTERVENTION PAYMENTS
95. TROPONIN LEVEL AT PRESENTATION IS A STRONG PREDICTOR OF OUTCOME FOR PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION FOR ST ELEVATION MYOCARDIAL INFARCTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR COLLABORATIVE (BMC2) REGISTRY
96. DAILY TEMPERATURE FLUCTUATIONS AND MYOCARDIAL INFARCTION: IMPLICATIONS OF GLOBAL WARMING ON CARDIAC HEALTH
97. Association Between Medicaid Expansion and Cardiovascular Interventions in Michigan
98. Reply: Treating Chronic Total Occlusions Successfully
99. TCT-608 Contemporary Use and Outcomes Associated with Rotational versus Orbital Atherectomy in Percutaneous Coronary Interventions: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
100. The comparative safety of abciximab versus eptifibatide in patients on dialysis undergoing percutaneous coronary intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.